Genesystem Co., Ltd. (KOSDAQ:363250)

Genesystem Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	41,430	27,964	59,357	65,169	58,004
Market Cap Growth	-45.35%	-52.89%	-8.92%	12.35%	-
Enterprise Value	43,497	30,673	56,608	-	-
Last Close Price	5000.00	4100.00	8440.00	9330.00	8370.00
Forward PE	-	14.85	14.85	14.85	-
PS Ratio	108.64	73.33	49.15	72.65	15.88
PB Ratio	5.35	3.61	2.71	2.12	1.65
P/TBV Ratio	5.74	3.88	4.79	3.28	1.69
EV/Sales Ratio	114.06	80.43	46.87	-	-
Debt / Equity Ratio	0.52	0.52	0.19	0.15	0.12
Net Debt / Equity Ratio	0.28	0.28	-0.16	-0.32	-0.64
Net Debt / EBITDA Ratio	-0.25	-0.25	0.40	1.10	3.60
Net Debt / FCF Ratio	-0.31	-0.31	0.47	1.21	3.37
Asset Turnover	0.02	0.02	0.04	0.02	-
Inventory Turnover	2.19	2.19	1.20	0.79	-
Quick Ratio	0.78	0.78	3.08	5.99	13.76
Current Ratio	1.08	1.08	3.93	8.65	15.50
Return on Equity (ROE)	-99.02%	-99.02%	-36.25%	-24.50%	-
Return on Assets (ROA)	-27.34%	-27.34%	-18.37%	-14.80%	-
Return on Capital Employed (ROCE)	-81.70%	-81.70%	-37.00%	-26.00%	-16.80%
Earnings Yield	-28.86%	-42.75%	-15.02%	-12.15%	-15.51%
FCF Yield	-17.14%	-25.40%	-12.80%	-12.54%	-11.47%
Buyback Yield / Dilution	0.46%	0.46%	1.47%	-0.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.